Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001047469-20-001217
Filing Date
2020-03-05
Accepted
2020-03-04 21:17:47
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-1/A a2240883zs-1a.htm S-1/A 80859
2 EX-4.10 a2240883zex-4_10.htm EX-4.10 126245
3 EX-4.11 a2240883zex-4_11.htm EX-4.11 130662
4 EX-4.12 a2240883zex-4_12.htm EX-4.12 130304
5 EX-10.26 a2240883zex-10_26.htm EX-10.26 222266
  Complete submission text file 0001047469-20-001217.txt   691480
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-236572 | Film No.: 20689419
SIC: 3841 Surgical & Medical Instruments & Apparatus